JPMorgan Chase & Co’s Adaptive Biotechnologies ADPT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$12.1M Sell
1,034,914
-49,269
-5% -$574K ﹤0.01% 2084
2025
Q1
$8.06M Buy
1,084,183
+424,977
+64% +$3.16M ﹤0.01% 2342
2024
Q4
$3.95M Sell
659,206
-228,627
-26% -$1.37M ﹤0.01% 2932
2024
Q3
$4.55M Sell
887,833
-14,724
-2% -$75.4K ﹤0.01% 2696
2024
Q2
$3.27M Buy
902,557
+689,050
+323% +$2.49M ﹤0.01% 2790
2024
Q1
$685K Sell
213,507
-68,461
-24% -$220K ﹤0.01% 3783
2023
Q4
$1.38M Sell
281,968
-20,156
-7% -$98.8K ﹤0.01% 3350
2023
Q3
$1.65M Sell
302,124
-9,072
-3% -$49.4K ﹤0.01% 3113
2023
Q2
$2.09M Sell
311,196
-212,552
-41% -$1.43M ﹤0.01% 3018
2023
Q1
$4.63M Buy
523,748
+120,353
+30% +$1.06M ﹤0.01% 2495
2022
Q4
$3.08M Sell
403,395
-140,849
-26% -$1.08M ﹤0.01% 2692
2022
Q3
$3.88M Sell
544,244
-16,544
-3% -$118K ﹤0.01% 2501
2022
Q2
$4.54M Buy
560,788
+231,673
+70% +$1.87M ﹤0.01% 2452
2022
Q1
$4.57M Buy
329,115
+49,451
+18% +$687K ﹤0.01% 2625
2021
Q4
$7.85M Buy
279,664
+96,280
+53% +$2.7M ﹤0.01% 2265
2021
Q3
$6.23M Sell
183,384
-13,959
-7% -$474K ﹤0.01% 2432
2021
Q2
$8.06M Sell
197,343
-1,191,290
-86% -$48.7M ﹤0.01% 2305
2021
Q1
$55.9M Buy
1,388,633
+62,566
+5% +$2.52M 0.01% 1029
2020
Q4
$78.4M Sell
1,326,067
-91,224
-6% -$5.39M 0.01% 804
2020
Q3
$68.1M Buy
1,417,291
+538,418
+61% +$25.9M 0.01% 779
2020
Q2
$42.5M Buy
878,873
+203,753
+30% +$9.86M 0.01% 901
2020
Q1
$18.8M Buy
675,120
+215,680
+47% +$5.99M ﹤0.01% 1182
2019
Q4
$13.7M Sell
459,440
-411,284
-47% -$12.3M ﹤0.01% 1569
2019
Q3
$26.9M Buy
870,724
+490,496
+129% +$15.2M 0.01% 1191
2019
Q2
$15.3M Buy
+380,228
New +$15.3M ﹤0.01% 1497